Research Comparison
GHK-Cu (Copper Tripeptide-1) vs KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV)
A side-by-side research comparison of GHK-Cu (Copper Tripeptide-1) and KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV) drawn from Cobalt Peptides' peptide database records.
GHK-Cu (Copper Tripeptide-1)
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine complexed with Cu²⁺) found in human plasma, saliva, and urine. Its endogenous levels decline significantly with age, correlating with reduced regenerative capacity and tissue repair. The peptide has been extensively studied for its role in skin regeneration, wound healing, and anti-aging. It influences a large proportion of human genes involved in repair, inflammation, and extracellular matrix remodeling, making it one of the most well-characterized regenerative peptides in dermatological and tissue repair research.
KLOW Stack (GHK-Cu + TB-500 + BPC-157 + KPV)
The KLOW Protocol is a four-peptide regenerative blend combining GHK-Cu, TB-500 (Thymosin Beta-4), BPC-157, and KPV. It builds upon the GLOW protocol by incorporating KPV, a tripeptide with anti-inflammatory activity, to enhance tolerability and broaden mechanistic coverage. Typical formulations contain approximately 50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, and 10mg KPV in a 5:1:1:1 ratio. While individual peptides have established research backgrounds, no clinical trials have evaluated this specific combination, and all effects remain theoretical based on additive and complementary mechanisms.